NEW YORK (GenomeWeb) – HTG Molecular Diagnostics reported after the close of the market on Thursday that its first quarter revenues fell 14 percent year over year, due in part to lower product sales.

The molecular-profiling instrument maker reported Q1 revenues fell to $865,232 from $1.0 million in Q1 2015. Service revenues rose sharply to $265,042 from $62,292 the year before, but were offset by a drop in product revenues to $600,190 from $727,438 in the year-ago period. Product revenues included $80,000 from instrument sales and $500,000 from the sale of consumables.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.